PRESS RELEASE
News
-
-
PRESS RELEASE
Communiqué de presse : Le Dupixent devient le tout premier biomédicament approuvé au Japon pour le traitement de la BPCO
Le Dupixent est le premier biomédicament approuvé au Japon pour traiter la BPCO, avec des résultats positifs provenant d'études de phase III. Paris, New York - 28 mars 2025 -
-
-
-
-
PRESS RELEASE
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
DBV Technologies secures financing of up to $306.9 million (€284.5 million) to advance Viaskin Peanut Patch through FDA submission and US commercial launch. Investors include MPM BioImpact, Adage Capital Management, Janus Henderson Investors, and more -
-
-
PRESS RELEASE
Prospect Ridge Announces Resignation of President and Director
Prospect Ridge Resources Corp. announces Mr. Yan Ducharme's resignation as President and Director, with Len Brownlie assuming the President role. Mike Iverson expresses gratitude for Yan's contribution and highlights exploration plans at Holy Grail and Knauss Creek projects
